I'm so sorry to hear of the unexpected issue with Dascor. I had heard that migration of the implant was an issue with both of the injectable nucleus replacements (Dascor and Nucore), but had not heard this.
The risk of being an early adopter of new technology is substantial. While we may complain about the cost and time involved in getting a new technology to the marketplace, the system can keep us from making serious mistakes. I know that is not much consolation for the Dascor clinical trial patients right now.
I hope to hear that this is not too serious and the levels are low. I don't understand how they can keep medical information about your case from you. When you go back and look at consent forms... can they control your records in a manner that keeps your data from you?
I'm sorry that you are facing this stressful issue.
Mark
|